Logo image of NHWK

NIGHTHAWK BIOSCIENCES INC (NHWK) Stock Price, Quote, News and Overview

NYSEARCA:NHWK - NYSE Arca - US42237K4094 - Common Stock - Currency: USD

0.4135  +0.03 (+8.96%)

After market: 0.4299 +0.02 (+3.97%)

NHWK Quote, Performance and Key Statistics

NIGHTHAWK BIOSCIENCES INC

NYSEARCA:NHWK (2/5/2024, 8:04:02 PM)

After market: 0.4299 +0.02 (+3.97%)

0.4135

+0.03 (+8.96%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High1.08
52 Week Low0.26
Market Cap36.34M
Shares87.88M
Float85.97M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-29 2024-03-29/amc
IPO07-24 2013-07-24


NHWK short term performance overview.The bars show the price performance of NHWK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30

NHWK long term performance overview.The bars show the price performance of NHWK in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of NHWK is 0.4135 USD. In the past month the price decreased by -8.05%. In the past year, price decreased by -60.24%.

NIGHTHAWK BIOSCIENCES INC / NHWK Daily stock chart

NHWK Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 17.83 323.41B
AMGN AMGEN INC 13.41 149.70B
GILD GILEAD SCIENCES INC 14.01 134.89B
VRTX VERTEX PHARMACEUTICALS INC N/A 114.30B
REGN REGENERON PHARMACEUTICALS 13.36 63.90B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 37.23B
ARGX ARGENX SE - ADR 98.17 35.18B
ONC BEIGENE LTD-ADR 6.15 25.99B
BNTX BIONTECH SE-ADR N/A 23.45B
NTRA NATERA INC N/A 22.01B
SMMT SUMMIT THERAPEUTICS INC N/A 19.34B
BIIB BIOGEN INC 8.06 18.69B

About NHWK

Company Profile

NHWK logo image NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 77 full-time employees. The company went IPO on 2013-07-24. Scorpius offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its clinical biomanufacturing capabilities include cGMP Mammalian Cell Culture and cGMP Microbial Fermentation. Its process development includes mammalian cell culture development, cell therapy development, microbial fermentation development, downstream process development and formulation development. The company also offers bioanalytical services, analytical methods development, pre-clinical and product development services, CMC analytical support services, bioassays and analytical technologies.

Company Info

NIGHTHAWK BIOSCIENCES INC

627 Davis Drive, Suite 300

Morrisville NORTH CAROLINA US

Employees: 77

NHWK Company Website

Phone: 19192407133

NIGHTHAWK BIOSCIENCES INC / NHWK FAQ

What is the stock price of NIGHTHAWK BIOSCIENCES INC today?

The current stock price of NHWK is 0.4135 USD. The price increased by 8.96% in the last trading session.


What is the ticker symbol for NIGHTHAWK BIOSCIENCES INC stock?

The exchange symbol of NIGHTHAWK BIOSCIENCES INC is NHWK and it is listed on the NYSE Arca exchange.


On which exchange is NHWK stock listed?

NHWK stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for NIGHTHAWK BIOSCIENCES INC stock?

6 analysts have analysed NHWK and the average price target is 10.2 USD. This implies a price increase of 2366.75% is expected in the next year compared to the current price of 0.4135. Check the NIGHTHAWK BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NIGHTHAWK BIOSCIENCES INC worth?

NIGHTHAWK BIOSCIENCES INC (NHWK) has a market capitalization of 36.34M USD. This makes NHWK a Nano Cap stock.


How many employees does NIGHTHAWK BIOSCIENCES INC have?

NIGHTHAWK BIOSCIENCES INC (NHWK) currently has 77 employees.


What are the support and resistance levels for NIGHTHAWK BIOSCIENCES INC (NHWK) stock?

NIGHTHAWK BIOSCIENCES INC (NHWK) has a support level at 0.37 and a resistance level at 0.44. Check the full technical report for a detailed analysis of NHWK support and resistance levels.


Is NIGHTHAWK BIOSCIENCES INC (NHWK) expected to grow?

The Revenue of NIGHTHAWK BIOSCIENCES INC (NHWK) is expected to decline by -28.99% in the next year. Check the estimates tab for more information on the NHWK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NIGHTHAWK BIOSCIENCES INC (NHWK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NIGHTHAWK BIOSCIENCES INC (NHWK) stock pay dividends?

NHWK does not pay a dividend.


When does NIGHTHAWK BIOSCIENCES INC (NHWK) report earnings?

NIGHTHAWK BIOSCIENCES INC (NHWK) will report earnings on 2024-03-29, after the market close.


What is the Price/Earnings (PE) ratio of NIGHTHAWK BIOSCIENCES INC (NHWK)?

NIGHTHAWK BIOSCIENCES INC (NHWK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.98).


NHWK Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NHWK. When comparing the yearly performance of all stocks, NHWK is a bad performer in the overall market: 90.35% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NHWK Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NHWK. NHWK has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NHWK Financial Highlights

Over the last trailing twelve months NHWK reported a non-GAAP Earnings per Share(EPS) of -1.98. The EPS decreased by -21.47% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -74.32%
ROE -143.11%
Debt/Equity 0.25
Chartmill High Growth Momentum
EPS Q2Q%1.96%
Sales Q2Q%1100%
EPS 1Y (TTM)-21.47%
Revenue 1Y (TTM)147.78%

NHWK Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to NHWK. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of -16.18% and a revenue growth -28.99% for NHWK


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts43.33
Price Target10.2 (2366.75%)
EPS Next Y-16.18%
Revenue Next Year-28.99%